Latest News about AMGN
Recent news which mentions AMGN
2 No-Brainer Biotech Stocks to Buy Right Now
December 22, 2022
From Motley Fool
Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday
December 22, 2022
From Benzinga
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
December 21, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 16, 2022
From Benzinga
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
From Motley Fool
The Best ETF For Dividend Yield And Dividend Growth
December 15, 2022
From Motley Fool
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
From Benzinga
Cramers Says These 3 Big Deals Aided Monday's Market Rally: 'When Companies Start Buying Each Other At A Big Premium...'
December 13, 2022
From Benzinga
Nasdaq, S&P 500 Futures Soar Amid Optimistic Expectations Concerning Nov. Inflation: Oracle, Tesla, Pinterest Among Early Movers
December 13, 2022
From Benzinga
Tesla, Apple, Rivian, Horizon, Paypal: Why These 5 Stocks Are Drawing Investors' Attention Today
December 12, 2022
From Benzinga
Here's Where Amgen's Loan To Acquire Horizon Therapeutics For $28B Ranks Among M&A Deals In 2022
December 12, 2022
From Benzinga
From MarketWatch
Why Horizon Therapeutics Stock Is Soaring Today
December 12, 2022
From Motley Fool
What's Going On With Amgen Stock Today?
December 12, 2022
From Benzinga
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
December 12, 2022
From InvestorPlace
These 2 Nasdaq Stocks Are Soaring on Merger News
December 12, 2022
From Motley Fool
From Benzinga
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
December 12, 2022
From Benzinga
Retail capitulation may be a new year’s gift for the stock market, says this analyst
December 12, 2022
From MarketWatch
Amgen reportedly in talks to buy Horizon Therapeutics
December 12, 2022
From MarketWatch
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
December 11, 2022
From Motley Fool
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
From Motley Fool
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
From Benzinga
Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy
December 06, 2022
From Benzinga
Is AbbVie Stock a Buy Now?
December 06, 2022
From Motley Fool
7 Christmas Stocks to Buy for Happy Holidays
December 05, 2022
From InvestorPlace
FTX Collapse: Lessons for Investors
December 03, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.